What standard practices should be in place for a stem cell provider to minimize risks of stem cell therapy treatment failures?

– Their labs should be compliant with FDA Current Good Manufacturing Practices (CGMP) and FDA Good Tissue Practices (GTP)

– Stem cells should be procured in a sterile, FDA compliant laboratory

– There should be strict testing standards in place for testing and quality control

– Stem cells from umbilical cord tissue should only be obtained with informed consent by donors

– Stem cells should be delivered to lab production facilities directly from the hospitals where they were donated

– Concentrations of stem cells should be standardized to ensure accurate treatment doses

– For optimal preservation, single-dose stem cell preparations should be shipped using dry ice

If you or anyone you know wants additional information or a stem cell consultation to evaluate alternatives to surgery, contact Stem Cell Therapy Rx in Tulsa, Oklahoma at 918-493-3824.

Here’s the video: https://youtu.be/DPIgr6BO-Dc

Here’s the link to our Facebook page: https://www.facebook.com/StemCellTherapyRx

Here’s a link to the YouTube channel: https://www.youtube.com/channel/UCEMpS–ePXzc3LkzuaPLK2w